PMS Study of Amlodipine/Valsartan for the Treatment of Hypertension

NCT02058446 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Essential Hypertension

Interventions

DRUG: Amlodipine/Valsartan

Sponsor

TSH Biopharm Corporation Limited